Most Recent Publications:
Brennan NA, Cheng X, Bullimore MA. Adult Myopia Progression. Invest Ophthalmol Vis Sci 2024;65:49.
Bullimore MA, Brennan NA. Efficacy in myopia control—The impact of rebound. Ophthalmic Physiol Opt 2024.
Brennan NA, Cheng X, Bullimore MA. Is the change in prevalence of high myopia compared to that of myopia really disproportionate? Transl Vis Sci Technol 2024;13:11.
Brennan NA, Shamp W, Maynes E, Cheng X, Bullimore MA. Influence of age and race on axial elongation in myopic children: a systematic review and meta-regression. Optom Vis Sci 2024;101:497-507.
Brennan NA, Nixon AD, Cheng X, Bullimore MA. Can we really distinguish ‘responders’ from ‘non-responders’ to myopia control interventions? Ophthalmic Physiol Opt 2024;44:136-1367.
Davies LN, Biswas S, Bullimore M, et al. BCLA CLEAR presbyopia: Mechanism and optics. Cont Lens Anterior Eye 2024:102185.
Wolffsohn JS, Naroo SA, Bullimore MA, et al. BCLA CLEAR Presbyopia: Definitions. Cont Lens Anterior Eye 2024:102155.
Bullimore MA, Jong M, Brennan NA. Myopia control: Seeing beyond efficacy. Optom Vis Sci 2024;101:134-42.
Hughes AR, Bullimore MA, Elliott DB. Ease of adaptation predicts patients’ preference and happiness with new spectacles better than visual acuity. Clin Exp Optom 2024:1-8.
Joseph A, Bullimore M, Drawnel F, et al. Remote Monitoring of Visual Function in Patients with Maculopathy: The Aphelion Study. Ophthalmol Ther 2024;13:409-22.
Bullimore MA, Morgan IG, Ohno-Matsui K, Saw SM. As Far as the Eye Can See: Importance of Myopia as a Pressing Public Health Need. Ophthalmol Sci 2024;4:100438
Bullimore MA, Brennan NA. Juvenile-Onset Myopia—Who to Treat and How to Evaluate Success? Eye (Lond) 2024;38:450-4.
Logan N, Bullimore MA. Optical Interventions for Myopia Control. Eye (Lond) 2024;38:455-63.
Jawaid I, Saunders K, Hammond C, Dahlmann-Noor A, Bullimore MA, Brennan NA. Low Concentration Atropine and Myopia: A Narrative Review of the Evidence for United Kingdom Based Practitioners. Eye (Lond) 2024;38:434-41.
Bullimore MA, Brennan NA. The underestimated role of myopia in uncorrectable visual impairment in the United States. Sci Rep 2023;13:15283.
Bullimore MA, Liu. Efficacy of the Euclid orthokeratology lens in slowing axial elongation. Cont Lens Anterior Eye 2023.
Bullimore MA, Lee SS, Schmid KL, et al. IMI - Onset and progression of myopia in young adults. Invest Ophthalmol Vis Sci 2023;64:2.
Sankaridurg P, Berntsen DA, Bullimore MA, et al. IMI - 2023 Digest. Invest Ophthalmol Vis Sci 2023;64:7.
Richdale K, Skidmore KV, Tomiyama ES, Bullimore MA. Compounded 0.01% Atropine-What's in the Bottle? Eye Contact Lens 2023;49:219-23.
Lattery LJ, Chao C, Walline J, Bullimore MA, Ritchey ER, Skidmore K, Richdale K. Patient and Parent Perceptions of Myopia Modalities. Cont Lens Anterior Eye 2023;46:101772.
Bullimore MA, Brennan NA, Flitcroft.The Future of Clinical Trials in Myopia Control. Ophthalmic Physiol Opt 2023;43:525-33.
Bullimore MA, Richdale K. Incidence of Corneal Adverse Events in Children Wearing Soft Contact Lenses. Eye Contact Lens 2023;49:204-11.
Bullimore MA, Brennan NA. Efficacy in Myopia Control—The Low-Concentration Atropine for Myopia Progression (LAMP) Study. Ophthalmology 2023;130:771-2.
Zhang J, Wu Y, Sharma B, et al. Epidemiology and Burden of Astigmatism: A Systematic Literature Review. Optom Vis Sci 2023;100:218-31.
Bullimore MA, Brennan NA. Efficacy in Myopia Control—Does Race Matter? Optom Vis Sci 2023;100:5-8.
Bullimore MA, Brennan NA. Myopia: An Ounce of Prevention is Worth a Pound of Cure. Ophthalmic Physiol Opt 2023;43:116-121.
Ducloux L, Marillet S, Ingrand P, Bullimore MA, Bourne R, Leveziel N. Progression of myopia in teenagers and adults: a nationwide longitudinal study of a prevalent cohort. Br J Ophthalmol 2023;107:644-9.